Inês Silva is a Medical Oncology Fellow and Researcher Scientist at Melanoma Institute Australia and The University of Sydney. She received her MD degree at the Universidade Nova de Lisboa (Portugal) in 2006 and completed specialist training in Medical Oncology at Instituto Português de Oncologia (Lisbon, Portugal) in 2016.
In 2010 she was chosen for the MD PhD Programme for Advanced Medical Education and earned a 3-year fellowship grant (sponsored by Gulbenkian and Champalimaud’s Foundations), providing her the opportunity to undertake research at Bhardwaj Lab, part of Interdisciplinary Melanoma Cooperative Group and NYU Cancer Institute (2010-2013). She completed her PhD thesis in tumour immunology, describing how the dysfunction of the protective innate immune mechanisms, including NK cells, can contribute towards melanoma progression. She did two clinical fellowships in melanoma, one at NYU Cancer Institute (2014) and more recently at Melanoma Institute Australia (2017), where she was co-investigator in phase I, II and III clinical trials in adjuvant and metastatic melanoma.
She has presented her research work in international meetings, and she has published original research and review articles. Her main research goal is to study mechanisms of innate and acquired resistance to immunotherapy in order to identify new therapeutic targets.